Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors

NCT04855656 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

464

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: Lunresertib
DRUG: RP-3500
DRUG: Debio0123

Sponsor

Debiopharm International SA